Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VEIL.AI has demonstrated that its next-generation anonymization technology can produce high-quality anonymized datasets suitable for secondary research use. In collaboration with Bayer and Findata, their solution enabled GDPR-compliant cross-border transfer of sensitive health data for clinical trial innovation. Their approach allows organizations to draw the same scientific conclusions from anonymized as from original pseudonymized datasets, supporting robust real-world evidence generation and AI model training without compromising privacy or regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VEIL.AI.